Alexander Nolte - 22 Oct 2021 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Accounting Officer
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
22 Oct 2021
Net transactions value
$0
Form type
3
Filing time
04 Nov 2021, 16:03:05 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 62,000 $21.36 Direct F1
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 35,000 $19.36 Direct F2
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 5,000 $18.03 Direct F3
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 2,000 $9.63 Direct F4
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 16,000 $9.47 Direct F5
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 11,667 $9.24 Direct F6
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 7,000 $9.00 Direct F7
holding SNDX Stock Options (Right to buy) 22 Oct 2021 Common Stock 18,000 $6.38 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2021, subject to the reporting person's continuous service on the relevant vesting dates.
F2 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning September 30, 2021, subject to the reporting person's continuous service on the relevant vesting dates.
F3 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning May 31, 2020, subject to the reporting person's continuous service on the relevant vesting dates.
F4 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2018, subject to the reporting person's continuous service on the relevant vesting dates.
F5 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 29, 2020, subject to the reporting person's continuous service on the relevant vesting dates.
F6 Twenty-five percent (25%) of the total number of shares underlying the option vested on May 1, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
F7 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning July 31, 2019, subject to the reporting person's continuous service on the relevant vesting dates.
F8 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2019, subject to the reporting person's continuous service on the relevant vesting dates.